Gsk Pharma
- All
- News
- Videos
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
GSK Pharma Net Profit Falls 90% To Rs 14 Crore In March Quarter
GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21
-
GlaxoSmithKline To Split After Joint Venture Deal With Pfizer
GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.
-
GSK Pharma Q2 Net Up 3% At Rs 99 Crore
It had posted net profit of Rs 95.55 crore for the July-September period of the previous fiscal.
-
Dr Reddy's Launches Seizures Treatment Tablets In US
Dr Reddy's Laboratories said its product is a generic version of GSK Group of companies' Lamictal tablets.
-
GSK, Alphabet Create $715 Million Bioelectronics Firm
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics.
-
GSK Pharma Reports 23% Fall In Q1 Net Profit
GlaxoSmithKline Pharmaceuticals on Thursday reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter, on account of increase in expenditure.
-
In Fight For GSK's Advair, Generic Firms Step Carefully On Price
Generic drugmakers, hoping for rich pickings from the launch of copies of GlaxoSmithKline's best-selling Advair inhaler in the United States next year, say they can win business without a race to the bottom on price.
-
GSK Gets EU Approval For First Gene Therapy For Children
The world's first life-saving gene therapy for children, developed by GlaxoSmithKline and Italian scientists, was approved for sale in Europe on Friday, in a step forward for the pioneering technology to fix faulty genes.
-
Beijing Aims to Refill Medicine Chest with 'Made in China' Drugs
China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and ageing population.
-
GlaxoSmithKline Pharma Posts 25% Drop in Q2 Profit
GlaxoSmithKline Pharmaceuticals on Saturday reported a 25.39 per cent dip in standalone net profit at Rs 96.05 crore for the fiscal second quarter that ended on September 30, 2015.
-
Sun Pharma Rises 2% on Acquiring Opiates Business in Australia
Sun Pharma in an announcement said that it acquired GSK's two opiates manufacturing facilities in Port Fairy and Latrobe in Australia.
-
Novartis India Gets Nod to Sell OTC Business to GSK CPL
Novartis India shares closed at Rs 799.5 apiece on BSE, down 0.88 per cent.
-
GSK Pharma's Bengaluru Facility to be Operational by 2017
The new site, which represents up to Rs 1,000 crore in investments, will be the first greenfield pharma site GSK has built across the globe over the past 10 years.
-
Considering All Options Against CCI Order: GlaxoSmithKline
Slapped with a penalty of nearly Rs 61 crore by the Competition Commission of India (CCI), GlaxoSmithKline Pharmaceuticals said on Monday that it would review the order and consider all options, including filing an appeal.
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
GSK Pharma Net Profit Falls 90% To Rs 14 Crore In March Quarter
GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21
-
GlaxoSmithKline To Split After Joint Venture Deal With Pfizer
GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.
-
GSK Pharma Q2 Net Up 3% At Rs 99 Crore
It had posted net profit of Rs 95.55 crore for the July-September period of the previous fiscal.
-
Dr Reddy's Launches Seizures Treatment Tablets In US
Dr Reddy's Laboratories said its product is a generic version of GSK Group of companies' Lamictal tablets.
-
GSK, Alphabet Create $715 Million Bioelectronics Firm
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics.
-
GSK Pharma Reports 23% Fall In Q1 Net Profit
GlaxoSmithKline Pharmaceuticals on Thursday reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter, on account of increase in expenditure.
-
In Fight For GSK's Advair, Generic Firms Step Carefully On Price
Generic drugmakers, hoping for rich pickings from the launch of copies of GlaxoSmithKline's best-selling Advair inhaler in the United States next year, say they can win business without a race to the bottom on price.
-
GSK Gets EU Approval For First Gene Therapy For Children
The world's first life-saving gene therapy for children, developed by GlaxoSmithKline and Italian scientists, was approved for sale in Europe on Friday, in a step forward for the pioneering technology to fix faulty genes.
-
Beijing Aims to Refill Medicine Chest with 'Made in China' Drugs
China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and ageing population.
-
GlaxoSmithKline Pharma Posts 25% Drop in Q2 Profit
GlaxoSmithKline Pharmaceuticals on Saturday reported a 25.39 per cent dip in standalone net profit at Rs 96.05 crore for the fiscal second quarter that ended on September 30, 2015.
-
Sun Pharma Rises 2% on Acquiring Opiates Business in Australia
Sun Pharma in an announcement said that it acquired GSK's two opiates manufacturing facilities in Port Fairy and Latrobe in Australia.
-
Novartis India Gets Nod to Sell OTC Business to GSK CPL
Novartis India shares closed at Rs 799.5 apiece on BSE, down 0.88 per cent.
-
GSK Pharma's Bengaluru Facility to be Operational by 2017
The new site, which represents up to Rs 1,000 crore in investments, will be the first greenfield pharma site GSK has built across the globe over the past 10 years.
-
Considering All Options Against CCI Order: GlaxoSmithKline
Slapped with a penalty of nearly Rs 61 crore by the Competition Commission of India (CCI), GlaxoSmithKline Pharmaceuticals said on Monday that it would review the order and consider all options, including filing an appeal.
